Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with 131I-MIP-1095 View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-06

AUTHORS

Ali Afshar-Oromieh, Uwe Haberkorn, Christian Zechmann, Thomas Armor, Walter Mier, Fabian Spohn, Nils Debus, Tim Holland-Letz, John Babich, Clemens Kratochwil

ABSTRACT

PURPOSE: Prostate-specific membrane antigen (PSMA)-targeting radioligand therapy (RLT) was introduced in 2011. The first report described the antitumor and side effects of a single dose. The aim of this analysis was to evaluate toxicity and antitumor activity after single and repetitive therapies. METHODS: Thirty-four men with metastatic castration-resistant prostate cancer received PSMA-RLT with 131I-MIP-1095. Twenty-three patients received a second, and three patients a third dose, timed at PSA progression after an initial response to the preceding therapy. The applied doses were separated in three groups: <3.5, 3.5-5.0 and >5.0 GBq. Antitumor and side-effects were analyzed by blood samples and other clinical data. Follow-up was conducted for up to 5 years. RESULTS: The best therapeutic effect was achieved by the first therapy. A PSA decline of ≥50% was achieved in 70.6% of the patients. The second and third therapies were significantly less effective. There was neither an association between the applied activity and PSA response or the time-to-progression. Hematologic toxicities were less prevalent but presented in a higher percentage of patients with increasing number of therapies. After hematologic toxicities, xerostomia was the second most frequent side effect and presented more often and with higher intensity after the second or third therapy. CONCLUSION: The first dose of RLT with 131I-MIP-1095 presented with low side effects and could significantly reduce the tumor burden in a majority of patients. The second and third therapies were less effective and presented with more frequent and more intense side effects, especially hematologic toxicities and xerostomia. More... »

PAGES

950-959

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00259-017-3665-9

DOI

http://dx.doi.org/10.1007/s00259-017-3665-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1084020150

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28280855


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, Surface", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Progression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glutamate Carboxypeptidase II", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glutamates", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Iodine Radioisotopes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ligands", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Metastasis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prostatic Neoplasms, Castration-Resistant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Safety", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Urea", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "German Cancer Research Center", 
          "id": "https://www.grid.ac/institutes/grid.7497.d", 
          "name": [
            "Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany", 
            "Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Afshar-Oromieh", 
        "givenName": "Ali", 
        "id": "sg:person.0601051525.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601051525.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "German Cancer Research Center", 
          "id": "https://www.grid.ac/institutes/grid.7497.d", 
          "name": [
            "Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany", 
            "Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Haberkorn", 
        "givenName": "Uwe", 
        "id": "sg:person.01142772466.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142772466.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospital Heidelberg", 
          "id": "https://www.grid.ac/institutes/grid.5253.1", 
          "name": [
            "Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zechmann", 
        "givenName": "Christian", 
        "id": "sg:person.01252656365.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252656365.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Progenics Pharmaceuticals (United States)", 
          "id": "https://www.grid.ac/institutes/grid.280766.d", 
          "name": [
            "Progenics Pharmaceuticals, Inc., New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Armor", 
        "givenName": "Thomas", 
        "id": "sg:person.0773211766.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0773211766.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospital Heidelberg", 
          "id": "https://www.grid.ac/institutes/grid.5253.1", 
          "name": [
            "Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mier", 
        "givenName": "Walter", 
        "id": "sg:person.01216712431.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216712431.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospital Heidelberg", 
          "id": "https://www.grid.ac/institutes/grid.5253.1", 
          "name": [
            "Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Spohn", 
        "givenName": "Fabian", 
        "id": "sg:person.015165131634.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015165131634.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospital Heidelberg", 
          "id": "https://www.grid.ac/institutes/grid.5253.1", 
          "name": [
            "Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Debus", 
        "givenName": "Nils", 
        "id": "sg:person.016305320067.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016305320067.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "German Cancer Research Center", 
          "id": "https://www.grid.ac/institutes/grid.7497.d", 
          "name": [
            "Department of Biostatistics, German Cancer Research Center, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Holland-Letz", 
        "givenName": "Tim", 
        "id": "sg:person.01342734010.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342734010.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cornell University", 
          "id": "https://www.grid.ac/institutes/grid.5386.8", 
          "name": [
            "Division of Radiopharmaceutical Sciences, Department of Radiology, Weill Cornell Medicine, New York, NY, USA", 
            "Citigroup Biomedical Imaging Center, Weill Cornell Medicine, 10021, New York, NY, USA", 
            "Meyer Cancer Center, Weill Cornell Medicine, 10021, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Babich", 
        "givenName": "John", 
        "id": "sg:person.0702220710.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702220710.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospital Heidelberg", 
          "id": "https://www.grid.ac/institutes/grid.5253.1", 
          "name": [
            "Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kratochwil", 
        "givenName": "Clemens", 
        "id": "sg:person.01151616225.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01151616225.91"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00259-016-3481-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002803441", 
          "https://doi.org/10.1007/s00259-016-3481-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-016-3481-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002803441", 
          "https://doi.org/10.1007/s00259-016-3481-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-13-0231", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005760736"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2004.09.154", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008865143"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13550-015-0114-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009225888", 
          "https://doi.org/10.1186/s13550-015-0114-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13550-015-0114-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009225888", 
          "https://doi.org/10.1186/s13550-015-0114-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/j.semnuclmed.2016.04.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011934265"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(14)71205-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013268426"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-015-3174-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013612188", 
          "https://doi.org/10.1007/s00259-015-3174-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-015-3174-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013612188", 
          "https://doi.org/10.1007/s00259-015-3174-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-014-2949-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017806742", 
          "https://doi.org/10.1007/s00259-014-2949-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-014-2949-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017806742", 
          "https://doi.org/10.1007/s00259-014-2949-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.juro.2016.02.2969", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017987601"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-09-1682", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023217681"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2967/jnumed.114.140426", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030345751"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-014-2713-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031124841", 
          "https://doi.org/10.1007/s00259-014-2713-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-014-2713-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031124841", 
          "https://doi.org/10.1007/s00259-014-2713-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(12)70379-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032592013"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18632/oncotarget.12240", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033028660"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11307-015-0850-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033167477", 
          "https://doi.org/10.1007/s11307-015-0850-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2013.09.026", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035344380"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.nucmedbio.2016.08.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036204574"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/rlu.0000000000001200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044170037"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/rlu.0000000000001200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044170037"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/rlu.0000000000001200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044170037"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2967/jnumed.112.111203", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044994053"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-016-3530-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047115242", 
          "https://doi.org/10.1007/s00259-016-3530-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-016-3530-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047115242", 
          "https://doi.org/10.1007/s00259-016-3530-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0090-4295(96)00184-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049889834"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/rlu.0000000000001240", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052140270"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/rlu.0000000000001240", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052140270"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/rlu.0000000000001240", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052140270"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-15-0820", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063224942"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2174/1874471008666150313114005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069234342"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2967/jnumed.115.168443", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070928389"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2967/jnumed.115.170720", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070928440"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2967/jnumed.115.171397", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070928459"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2967/jnumed.116.173757", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070928498"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2967/jnumed.116.178228", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070928571"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2967/jnumed.116.183194", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070928663"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2967/jnumed.116.183194", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070928663"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077048096", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-06", 
    "datePublishedReg": "2017-06-01", 
    "description": "PURPOSE: Prostate-specific membrane antigen (PSMA)-targeting radioligand therapy (RLT) was introduced in 2011. The first report described the antitumor and side effects of a single dose. The aim of this analysis was to evaluate toxicity and antitumor activity after single and repetitive therapies.\nMETHODS: Thirty-four men with metastatic castration-resistant prostate cancer received PSMA-RLT with 131I-MIP-1095. Twenty-three patients received a second, and three patients a third dose, timed at PSA progression after an initial response to the preceding therapy. The applied doses were separated in three groups: <3.5, 3.5-5.0 and >5.0\u00a0GBq. Antitumor and side-effects were analyzed by blood samples and other clinical data. Follow-up was conducted for up to 5\u00a0years.\nRESULTS: The best therapeutic effect was achieved by the first therapy. A PSA decline of \u226550% was achieved in 70.6% of the patients. The second and third therapies were significantly less effective. There was neither an association between the applied activity and PSA response or the time-to-progression. Hematologic toxicities were less prevalent but presented in a higher percentage of patients with increasing number of therapies. After hematologic toxicities, xerostomia was the second most frequent side effect and presented more often and with higher intensity after the second or third therapy.\nCONCLUSION: The first dose of RLT with 131I-MIP-1095 presented with low side effects and could significantly reduce the tumor burden in a majority of patients. The second and third therapies were less effective and presented with more frequent and more intense side effects, especially hematologic toxicities and xerostomia.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00259-017-3665-9", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1297401", 
        "issn": [
          "1619-7070", 
          "1619-7089"
        ], 
        "name": "European Journal of Nuclear Medicine and Molecular Imaging", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "44"
      }
    ], 
    "name": "Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with 131I-MIP-1095", 
    "pagination": "950-959", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "d8dfb9f9d446281125dd648c7a336aa2e6efa3e678934f3f813d6ebb1e4fcab7"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28280855"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101140988"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00259-017-3665-9"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1084020150"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00259-017-3665-9", 
      "https://app.dimensions.ai/details/publication/pub.1084020150"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T10:39", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000349_0000000349/records_113679_00000004.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs00259-017-3665-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00259-017-3665-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00259-017-3665-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00259-017-3665-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00259-017-3665-9'


 

This table displays all metadata directly associated to this object as RDF triples.

300 TRIPLES      21 PREDICATES      74 URIs      35 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00259-017-3665-9 schema:about N0bac3639e8414cc0b05d3508fed3a639
2 N0e24eaa7422c446292ed0b7cc7171d90
3 N2f8626a2af55411f83b0007abf336430
4 N3a453bec57624ec6b8577927842abd92
5 N3e4c45e2a8a84d8cb94281f2dd17be22
6 N40e9389a10a44378905852b5af77a8b4
7 N61251874cf6846d299438748725ca632
8 N7d9aad5a291c459793930c69545e27e1
9 N8543853003be4c49bbd3e2c11ac19ab4
10 N9a927abf98294a83b583d7e1c40192dd
11 N9d41a76bd4f041d6a3715f44d1db8a5e
12 Nb2a31030aa2f44cb8f6dcbbdf4b140a0
13 Nf621ba0c84f54ea79029b06c31fd1224
14 Nfa055cbbaf4a4a618904899c7e426e4a
15 anzsrc-for:11
16 anzsrc-for:1103
17 schema:author N714517f6ebe1475e8f1462e1d909b2c4
18 schema:citation sg:pub.10.1007/s00259-014-2713-y
19 sg:pub.10.1007/s00259-014-2949-6
20 sg:pub.10.1007/s00259-015-3174-7
21 sg:pub.10.1007/s00259-016-3481-7
22 sg:pub.10.1007/s00259-016-3530-2
23 sg:pub.10.1007/s11307-015-0850-8
24 sg:pub.10.1186/s13550-015-0114-2
25 https://app.dimensions.ai/details/publication/pub.1077048096
26 https://doi.org/10.1016/j.ejca.2013.09.026
27 https://doi.org/10.1016/j.juro.2016.02.2969
28 https://doi.org/10.1016/j.nucmedbio.2016.08.003
29 https://doi.org/10.1016/s0090-4295(96)00184-7
30 https://doi.org/10.1016/s1470-2045(12)70379-0
31 https://doi.org/10.1016/s1470-2045(14)71205-7
32 https://doi.org/10.1053/j.semnuclmed.2016.04.004
33 https://doi.org/10.1097/rlu.0000000000001200
34 https://doi.org/10.1097/rlu.0000000000001240
35 https://doi.org/10.1158/0008-5472.can-09-1682
36 https://doi.org/10.1158/1078-0432.ccr-13-0231
37 https://doi.org/10.1158/1078-0432.ccr-15-0820
38 https://doi.org/10.1200/jco.2004.09.154
39 https://doi.org/10.18632/oncotarget.12240
40 https://doi.org/10.2174/1874471008666150313114005
41 https://doi.org/10.2967/jnumed.112.111203
42 https://doi.org/10.2967/jnumed.114.140426
43 https://doi.org/10.2967/jnumed.115.168443
44 https://doi.org/10.2967/jnumed.115.170720
45 https://doi.org/10.2967/jnumed.115.171397
46 https://doi.org/10.2967/jnumed.116.173757
47 https://doi.org/10.2967/jnumed.116.178228
48 https://doi.org/10.2967/jnumed.116.183194
49 schema:datePublished 2017-06
50 schema:datePublishedReg 2017-06-01
51 schema:description PURPOSE: Prostate-specific membrane antigen (PSMA)-targeting radioligand therapy (RLT) was introduced in 2011. The first report described the antitumor and side effects of a single dose. The aim of this analysis was to evaluate toxicity and antitumor activity after single and repetitive therapies. METHODS: Thirty-four men with metastatic castration-resistant prostate cancer received PSMA-RLT with 131I-MIP-1095. Twenty-three patients received a second, and three patients a third dose, timed at PSA progression after an initial response to the preceding therapy. The applied doses were separated in three groups: <3.5, 3.5-5.0 and >5.0 GBq. Antitumor and side-effects were analyzed by blood samples and other clinical data. Follow-up was conducted for up to 5 years. RESULTS: The best therapeutic effect was achieved by the first therapy. A PSA decline of ≥50% was achieved in 70.6% of the patients. The second and third therapies were significantly less effective. There was neither an association between the applied activity and PSA response or the time-to-progression. Hematologic toxicities were less prevalent but presented in a higher percentage of patients with increasing number of therapies. After hematologic toxicities, xerostomia was the second most frequent side effect and presented more often and with higher intensity after the second or third therapy. CONCLUSION: The first dose of RLT with 131I-MIP-1095 presented with low side effects and could significantly reduce the tumor burden in a majority of patients. The second and third therapies were less effective and presented with more frequent and more intense side effects, especially hematologic toxicities and xerostomia.
52 schema:genre research_article
53 schema:inLanguage en
54 schema:isAccessibleForFree true
55 schema:isPartOf N2946a4ab40a043ad8af5988481e185de
56 Nd3ccb3b202f14e96a8e26dfe49e6cb9f
57 sg:journal.1297401
58 schema:name Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with 131I-MIP-1095
59 schema:pagination 950-959
60 schema:productId N2ab130fcf845450796a1c38bdfcd58ee
61 N43c21a6d2c284f6db6c6e39d6301786d
62 N65d3c19907554a97a47f49ad9b42810c
63 N7262a79506924b44a892d7fe154186e4
64 Nc3c0a81cd294461282a9864e9835870f
65 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084020150
66 https://doi.org/10.1007/s00259-017-3665-9
67 schema:sdDatePublished 2019-04-11T10:39
68 schema:sdLicense https://scigraph.springernature.com/explorer/license/
69 schema:sdPublisher N9dea165cd62440f88e5e17229079d989
70 schema:url https://link.springer.com/10.1007%2Fs00259-017-3665-9
71 sgo:license sg:explorer/license/
72 sgo:sdDataset articles
73 rdf:type schema:ScholarlyArticle
74 N0bac3639e8414cc0b05d3508fed3a639 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Antigens, Surface
76 rdf:type schema:DefinedTerm
77 N0d2f5295d1454813b3cb8310bc8aba78 rdf:first sg:person.0702220710.66
78 rdf:rest Nfe7c089ff42442f1b08ab91cca8b3f26
79 N0e24eaa7422c446292ed0b7cc7171d90 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Glutamates
81 rdf:type schema:DefinedTerm
82 N2946a4ab40a043ad8af5988481e185de schema:volumeNumber 44
83 rdf:type schema:PublicationVolume
84 N2ab130fcf845450796a1c38bdfcd58ee schema:name dimensions_id
85 schema:value pub.1084020150
86 rdf:type schema:PropertyValue
87 N2f8626a2af55411f83b0007abf336430 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Male
89 rdf:type schema:DefinedTerm
90 N3a453bec57624ec6b8577927842abd92 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Retrospective Studies
92 rdf:type schema:DefinedTerm
93 N3e4c45e2a8a84d8cb94281f2dd17be22 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Survival Analysis
95 rdf:type schema:DefinedTerm
96 N40e9389a10a44378905852b5af77a8b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Urea
98 rdf:type schema:DefinedTerm
99 N43c21a6d2c284f6db6c6e39d6301786d schema:name nlm_unique_id
100 schema:value 101140988
101 rdf:type schema:PropertyValue
102 N44b2e4c2ad034b649fda842ea4e0ee06 rdf:first sg:person.01142772466.17
103 rdf:rest Ne3db2e91b61b45c79528912ecf51943d
104 N5517f7a231b54ebba6c193ce4f512bdd rdf:first sg:person.015165131634.68
105 rdf:rest Naa6961ee41c1484d9d47850bf45a1a33
106 N61251874cf6846d299438748725ca632 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Iodine Radioisotopes
108 rdf:type schema:DefinedTerm
109 N65d3c19907554a97a47f49ad9b42810c schema:name pubmed_id
110 schema:value 28280855
111 rdf:type schema:PropertyValue
112 N714517f6ebe1475e8f1462e1d909b2c4 rdf:first sg:person.0601051525.56
113 rdf:rest N44b2e4c2ad034b649fda842ea4e0ee06
114 N7262a79506924b44a892d7fe154186e4 schema:name readcube_id
115 schema:value d8dfb9f9d446281125dd648c7a336aa2e6efa3e678934f3f813d6ebb1e4fcab7
116 rdf:type schema:PropertyValue
117 N7d9aad5a291c459793930c69545e27e1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Safety
119 rdf:type schema:DefinedTerm
120 N8543853003be4c49bbd3e2c11ac19ab4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Glutamate Carboxypeptidase II
122 rdf:type schema:DefinedTerm
123 N86a25b59241d4533ab2c1aff120f8b31 rdf:first sg:person.0773211766.00
124 rdf:rest Nacbc6df366af456c84e6193d9315942f
125 N9a927abf98294a83b583d7e1c40192dd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Prostatic Neoplasms, Castration-Resistant
127 rdf:type schema:DefinedTerm
128 N9d41a76bd4f041d6a3715f44d1db8a5e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Ligands
130 rdf:type schema:DefinedTerm
131 N9dea165cd62440f88e5e17229079d989 schema:name Springer Nature - SN SciGraph project
132 rdf:type schema:Organization
133 Naa6961ee41c1484d9d47850bf45a1a33 rdf:first sg:person.016305320067.63
134 rdf:rest Nfc1349f0d5744ae09f44c65ff7eeb59c
135 Nacbc6df366af456c84e6193d9315942f rdf:first sg:person.01216712431.54
136 rdf:rest N5517f7a231b54ebba6c193ce4f512bdd
137 Nb2a31030aa2f44cb8f6dcbbdf4b140a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Neoplasm Metastasis
139 rdf:type schema:DefinedTerm
140 Nc3c0a81cd294461282a9864e9835870f schema:name doi
141 schema:value 10.1007/s00259-017-3665-9
142 rdf:type schema:PropertyValue
143 Nd3ccb3b202f14e96a8e26dfe49e6cb9f schema:issueNumber 6
144 rdf:type schema:PublicationIssue
145 Ne3db2e91b61b45c79528912ecf51943d rdf:first sg:person.01252656365.95
146 rdf:rest N86a25b59241d4533ab2c1aff120f8b31
147 Nf621ba0c84f54ea79029b06c31fd1224 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Disease Progression
149 rdf:type schema:DefinedTerm
150 Nfa055cbbaf4a4a618904899c7e426e4a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Humans
152 rdf:type schema:DefinedTerm
153 Nfc1349f0d5744ae09f44c65ff7eeb59c rdf:first sg:person.01342734010.26
154 rdf:rest N0d2f5295d1454813b3cb8310bc8aba78
155 Nfe7c089ff42442f1b08ab91cca8b3f26 rdf:first sg:person.01151616225.91
156 rdf:rest rdf:nil
157 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
158 schema:name Medical and Health Sciences
159 rdf:type schema:DefinedTerm
160 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
161 schema:name Clinical Sciences
162 rdf:type schema:DefinedTerm
163 sg:journal.1297401 schema:issn 1619-7070
164 1619-7089
165 schema:name European Journal of Nuclear Medicine and Molecular Imaging
166 rdf:type schema:Periodical
167 sg:person.01142772466.17 schema:affiliation https://www.grid.ac/institutes/grid.7497.d
168 schema:familyName Haberkorn
169 schema:givenName Uwe
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142772466.17
171 rdf:type schema:Person
172 sg:person.01151616225.91 schema:affiliation https://www.grid.ac/institutes/grid.5253.1
173 schema:familyName Kratochwil
174 schema:givenName Clemens
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01151616225.91
176 rdf:type schema:Person
177 sg:person.01216712431.54 schema:affiliation https://www.grid.ac/institutes/grid.5253.1
178 schema:familyName Mier
179 schema:givenName Walter
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216712431.54
181 rdf:type schema:Person
182 sg:person.01252656365.95 schema:affiliation https://www.grid.ac/institutes/grid.5253.1
183 schema:familyName Zechmann
184 schema:givenName Christian
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252656365.95
186 rdf:type schema:Person
187 sg:person.01342734010.26 schema:affiliation https://www.grid.ac/institutes/grid.7497.d
188 schema:familyName Holland-Letz
189 schema:givenName Tim
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342734010.26
191 rdf:type schema:Person
192 sg:person.015165131634.68 schema:affiliation https://www.grid.ac/institutes/grid.5253.1
193 schema:familyName Spohn
194 schema:givenName Fabian
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015165131634.68
196 rdf:type schema:Person
197 sg:person.016305320067.63 schema:affiliation https://www.grid.ac/institutes/grid.5253.1
198 schema:familyName Debus
199 schema:givenName Nils
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016305320067.63
201 rdf:type schema:Person
202 sg:person.0601051525.56 schema:affiliation https://www.grid.ac/institutes/grid.7497.d
203 schema:familyName Afshar-Oromieh
204 schema:givenName Ali
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601051525.56
206 rdf:type schema:Person
207 sg:person.0702220710.66 schema:affiliation https://www.grid.ac/institutes/grid.5386.8
208 schema:familyName Babich
209 schema:givenName John
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702220710.66
211 rdf:type schema:Person
212 sg:person.0773211766.00 schema:affiliation https://www.grid.ac/institutes/grid.280766.d
213 schema:familyName Armor
214 schema:givenName Thomas
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0773211766.00
216 rdf:type schema:Person
217 sg:pub.10.1007/s00259-014-2713-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1031124841
218 https://doi.org/10.1007/s00259-014-2713-y
219 rdf:type schema:CreativeWork
220 sg:pub.10.1007/s00259-014-2949-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017806742
221 https://doi.org/10.1007/s00259-014-2949-6
222 rdf:type schema:CreativeWork
223 sg:pub.10.1007/s00259-015-3174-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013612188
224 https://doi.org/10.1007/s00259-015-3174-7
225 rdf:type schema:CreativeWork
226 sg:pub.10.1007/s00259-016-3481-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002803441
227 https://doi.org/10.1007/s00259-016-3481-7
228 rdf:type schema:CreativeWork
229 sg:pub.10.1007/s00259-016-3530-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047115242
230 https://doi.org/10.1007/s00259-016-3530-2
231 rdf:type schema:CreativeWork
232 sg:pub.10.1007/s11307-015-0850-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033167477
233 https://doi.org/10.1007/s11307-015-0850-8
234 rdf:type schema:CreativeWork
235 sg:pub.10.1186/s13550-015-0114-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009225888
236 https://doi.org/10.1186/s13550-015-0114-2
237 rdf:type schema:CreativeWork
238 https://app.dimensions.ai/details/publication/pub.1077048096 schema:CreativeWork
239 https://doi.org/10.1016/j.ejca.2013.09.026 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035344380
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1016/j.juro.2016.02.2969 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017987601
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1016/j.nucmedbio.2016.08.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036204574
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1016/s0090-4295(96)00184-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049889834
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1016/s1470-2045(12)70379-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032592013
248 rdf:type schema:CreativeWork
249 https://doi.org/10.1016/s1470-2045(14)71205-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013268426
250 rdf:type schema:CreativeWork
251 https://doi.org/10.1053/j.semnuclmed.2016.04.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011934265
252 rdf:type schema:CreativeWork
253 https://doi.org/10.1097/rlu.0000000000001200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044170037
254 rdf:type schema:CreativeWork
255 https://doi.org/10.1097/rlu.0000000000001240 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052140270
256 rdf:type schema:CreativeWork
257 https://doi.org/10.1158/0008-5472.can-09-1682 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023217681
258 rdf:type schema:CreativeWork
259 https://doi.org/10.1158/1078-0432.ccr-13-0231 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005760736
260 rdf:type schema:CreativeWork
261 https://doi.org/10.1158/1078-0432.ccr-15-0820 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063224942
262 rdf:type schema:CreativeWork
263 https://doi.org/10.1200/jco.2004.09.154 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008865143
264 rdf:type schema:CreativeWork
265 https://doi.org/10.18632/oncotarget.12240 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033028660
266 rdf:type schema:CreativeWork
267 https://doi.org/10.2174/1874471008666150313114005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069234342
268 rdf:type schema:CreativeWork
269 https://doi.org/10.2967/jnumed.112.111203 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044994053
270 rdf:type schema:CreativeWork
271 https://doi.org/10.2967/jnumed.114.140426 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030345751
272 rdf:type schema:CreativeWork
273 https://doi.org/10.2967/jnumed.115.168443 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070928389
274 rdf:type schema:CreativeWork
275 https://doi.org/10.2967/jnumed.115.170720 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070928440
276 rdf:type schema:CreativeWork
277 https://doi.org/10.2967/jnumed.115.171397 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070928459
278 rdf:type schema:CreativeWork
279 https://doi.org/10.2967/jnumed.116.173757 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070928498
280 rdf:type schema:CreativeWork
281 https://doi.org/10.2967/jnumed.116.178228 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070928571
282 rdf:type schema:CreativeWork
283 https://doi.org/10.2967/jnumed.116.183194 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070928663
284 rdf:type schema:CreativeWork
285 https://www.grid.ac/institutes/grid.280766.d schema:alternateName Progenics Pharmaceuticals (United States)
286 schema:name Progenics Pharmaceuticals, Inc., New York, NY, USA
287 rdf:type schema:Organization
288 https://www.grid.ac/institutes/grid.5253.1 schema:alternateName University Hospital Heidelberg
289 schema:name Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany
290 rdf:type schema:Organization
291 https://www.grid.ac/institutes/grid.5386.8 schema:alternateName Cornell University
292 schema:name Citigroup Biomedical Imaging Center, Weill Cornell Medicine, 10021, New York, NY, USA
293 Division of Radiopharmaceutical Sciences, Department of Radiology, Weill Cornell Medicine, New York, NY, USA
294 Meyer Cancer Center, Weill Cornell Medicine, 10021, New York, NY, USA
295 rdf:type schema:Organization
296 https://www.grid.ac/institutes/grid.7497.d schema:alternateName German Cancer Research Center
297 schema:name Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany
298 Department of Biostatistics, German Cancer Research Center, Heidelberg, Germany
299 Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany
300 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...